PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
PHAS
Delisted
PHAS was delisted on the 2nd of November, 2022.
49 hedge funds and large institutions have $14M invested in PhaseBio Pharmaceuticals, Inc. Common Stock in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 13 closing their positions.
Holders
49
Holders Change
-7
Holders Change %
-12.5%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
12
Reduced
13
Closed
13
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
